Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemia

Horse-derived anti-thymocyte globulin (ATGAM) in combination with long-term ciclosporin is the first-line treatment for most immune-mediated aplastic anemia (AA) patients. The exact impact of this immunosuppressive therapy (IST) on hematological recovery and the immune landscape, however, remains p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Emma S. Pool, Cilia R. Pothast, Shannah M. Gennesse, Esther H.M. van Egmond, Julia M. Giezen, Sabrina A.J. Veld, René E.M. Toes, Frits Koning, Constantijn J.M. Halkes, Mirjam H.M. Heemskerk, Dirk Jan A.R. Moes, Jennifer M-L. Tjon
Format:	Artigo
Idioma:	Inglês
Publicat:	Ferrata Storti Foundation 2026-01-01
Col·lecció:	Haematologica
Accés en línia:	https://haematologica.org/article/view/13129
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!